ACE Inhibitors
Coronary flow response to bradykinin is preserved by ACE inhibitors in aged mice
Published in Obesity and Diabetes Week, January 17th, 2005
According to recent research from Japan, "ACE inhibitors are known to ameliorate cardiovascular complications in aging; however, their effects on the coronary circulation in relation to aging and eNOS dependence remain to be examined."
M.A. Talukder and colleagues of Kyushu University explained, "Coronary flow responses to bradykinin with or without ACE inhibitors were examined in Langendorff-perfused hearts from young (16-20 weeks) and aged (16-20 months) control and eNOS-/- mice....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Genomics and Genetics
Polymorphism affects PAI-1 response to vitamin E in type 2 diabetic patients - Diabetes Pathogenesis
Mechanism of caffeine inhibition of glucose uptake in adipose cells outlined - Diabetes Risk Factor
Effect of ACE gene polymorphism on insulin secretion affected by birth weight - Diabetes Therapy
Exercise improves aspects of heart disease in type 2 diabetic patients - Metabolic Syndrome
Stability of variables linked to metabolic syndrome outlined - Atherosclerosis
Cardiac effects of sera PAPP-A studied in type 2 diabetics with high LDL - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
